SEVIKAR Trademark

Trademark Overview


On Friday, October 29, 2021, a trademark application was filed for SEVIKAR with the United States Patent and Trademark Office. The USPTO has given the SEVIKAR trademark a serial number of 97099353. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Friday, March 29, 2024. This trademark is owned by DAIICHI SANKYO COMPANY, LIMITED. The SEVIKAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, cancer, oncological disease, metastasis, autoimmune disease, allergy, bacterial infection, viral infection, fungal infection, inflammation, musculoskeletal disorders, pain, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease, gastrointestinal disease; vaccines; diagnostic reagents and contrast media for medical use
sevikar

General Information


Serial Number97099353
Word MarkSEVIKAR
Filing DateFriday, October 29, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateFriday, March 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 23, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, cancer, oncological disease, metastasis, autoimmune disease, allergy, bacterial infection, viral infection, fungal infection, inflammation, musculoskeletal disorders, pain, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease, gastrointestinal disease; vaccines; diagnostic reagents and contrast media for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressChuo-ko, Tokyo 103-8426
JP

Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressChuo-ko, Tokyo 103-8426
JP

Trademark Events


Event DateEvent Description
Saturday, March 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 29, 2024SOU EXTENSION 3 GRANTED
Friday, March 29, 2024SOU EXTENSION 3 FILED
Friday, March 29, 2024SOU TEAS EXTENSION RECEIVED
Saturday, October 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 5, 2023SOU EXTENSION 2 GRANTED
Thursday, October 5, 2023SOU EXTENSION 2 FILED
Thursday, October 5, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 22, 2023SOU EXTENSION 1 GRANTED
Wednesday, March 22, 2023SOU EXTENSION 1 FILED
Wednesday, March 22, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 18, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 23, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 23, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 3, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 14, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 14, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 14, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 11, 2022NON-FINAL ACTION E-MAILED
Friday, March 11, 2022NON-FINAL ACTION WRITTEN
Monday, March 7, 2022ASSIGNED TO EXAMINER
Wednesday, November 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 2, 2021NEW APPLICATION ENTERED